These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The involvement of lipids in Alzheimer's disease. Lim WL; Martins IJ; Martins RN J Genet Genomics; 2014 May; 41(5):261-74. PubMed ID: 24894353 [TBL] [Abstract][Full Text] [Related]
5. Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer's disease? Michikawa M J Neurosci Res; 2003 Apr; 72(2):141-6. PubMed ID: 12671988 [TBL] [Abstract][Full Text] [Related]
6. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E. Fan J; Donkin J; Wellington C Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492 [TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele. Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251 [TBL] [Abstract][Full Text] [Related]
9. Cholesterol and Alzheimer's disease--is there a relation? Sjögren M; Mielke M; Gustafson D; Zandi P; Skoog I Mech Ageing Dev; 2006 Feb; 127(2):138-47. PubMed ID: 16332384 [TBL] [Abstract][Full Text] [Related]
10. Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease. Bales KR Neuropharmacology; 2010; 59(4-5):295-302. PubMed ID: 20079752 [TBL] [Abstract][Full Text] [Related]
11. [Risk factors for Alzheimer's disease]. Yanagisawa K Rinsho Shinkeigaku; 2000 Dec; 40(12):1225-7. PubMed ID: 11464462 [TBL] [Abstract][Full Text] [Related]
12. ApoE: the link between Alzheimer's-related glucose hypometabolism and Aβ deposition? Patil SP; Ballard R; Sanchez S; Osborn J; Santangelo D Med Hypotheses; 2012 Apr; 78(4):494-6. PubMed ID: 22285195 [TBL] [Abstract][Full Text] [Related]
13. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Chen Z; Zhong C Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology. Baum L; Chen L; Ng HK; Pang CP Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880 [TBL] [Abstract][Full Text] [Related]
15. The link between cholesterol and Alzheimer's disease. Sjögren M; Blennow K World J Biol Psychiatry; 2005; 6(2):85-97. PubMed ID: 16156481 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. Hsiung GY; Sadovnick AD; Feldman H CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624 [TBL] [Abstract][Full Text] [Related]
17. [Expression of apolipoprotein E in Alzheimer's disease and its significance]. He SR; Liu DG; Wang S; Xia YJ Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304 [TBL] [Abstract][Full Text] [Related]